Skrine guides Malaysia’s Ekuinas into pharma 

0
909
Ekuinas pharma medspec
LinkedIn
Facebook
Twitter
Whatsapp
Telegram
Copy link

Ekuiti Nasional (Ekuinas), a private equity company owned by the Malaysian government, has acquired a controlling stake in a local pharmaceutical company, Medispec, an enterprise valued at MYR88.5 million (US$21.9 million).

With a track record spanning more than 35 years, Medispec is a leading distributor of healthcare and pharmaceutical products in Malaysia across clinics, pharmacies, and private and public hospitals. It offers more than 100 drugs and 30 supplements under both prescription and over-the-counter categories.

You must be a subscribersubscribersubscribersubscriber to read this content, please subscribesubscribesubscribesubscribe today.

For group subscribers, please click here to access.
Interested in group subscription? Please contact us.

你需要登录去解锁本文内容。欢迎注册账号。如果想阅读月刊所有文章,欢迎成为我们的订阅会员成为我们的订阅会员

已有集团订阅,可点击此处继续浏览。
如对集团订阅感兴趣,请联络我们

LinkedIn
Facebook
Twitter
Whatsapp
Telegram
Copy link